Health Care Stocks News: Cochlear (COH)|ASX COH|COH SharesCochlear (ASX:COH) is a world leader in restoring hearing to profoundly hearing-impaired patients.

The company currently occupies a 70% share of the world market for the profoundly hearing impaired (PHI), selling its products in over 100 countries.

COH shares have been smashed today after the group recalled its latest hearing implant range.

The voluntary recall of COH’s Nucleus CI500 range was in response to a recent increase in implant failures.

The group’s shares have been trading lower by more than 20% so far today, making COH the worst performer in the stock market.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!


   Written by: admin   Other posts from: admin

Resmed RMD ASXResmed (RMD) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders such as sleep apnoea.

RMD operates in over 65 countries through 16 direct offices and a network of distributors, including Australia, France, Germany, New Zealand, Singapore, the UK and the United States.

Last week, RMD announced a 1H11 net profit of US$115.2 million, up 30.7% from a year earlier.

Revenue increased 12.6% to US$359,953, driven by growth in flow generators and masks sales.

Resmed said it expects growth of all of its products to continue to benefit from the growth in the sleep-disordered breathing market.

RMD lost 2.1% last week, underperforming the share market, which gained 0.4%.

Keep up to date with RMD and all Health Care Stocks with a free trial.




   Written by: admin   Other posts from: admin
7 day free trial
 



asx-share-price

To start your Free 7 day trial please complete your details below

* required fields

IMPORTANT: an activation code will be sent via SMS, please enter your preferred mobile number



Disclaimer: The content of this blog does not constitute a recommendation nor does it take into account your investment objectives, financial situation nor particular needs. Before acquiring or using any of Australian Stock Report's products, you should obtain and consider our Financial Services Guide. Australian Stock Report Ltd (ACN 106 863 978) is licensed as an Australian Financial Services Licensee pursuant to section 913B of the Corporations Act 2001. AFS Licence 301682. Any content within this email remains the property of Australian Stock Report and should not be reproduced without the consent of Australian Stock Report
RSS Feed